Abstract |
S(-)-Satropane is currently being developed to in situ forming ophthalmic gel, a new ophthalmic delivery system, for the treatment of glaucoma. To evaluate the pharmacokinetic profiles of S(-)-satropane, the microdialysis method was employed. The concentration of S(-)-satropane in dialysates was measured by using liquid chromatography/tandem mass spectrometry (LC-MS/MS). Unlike the common solution prepared in normal saline, in which the level of S(-)-satropane in aqueous humor increased rapidly after instillation and reached the maximal level (C(max) of 1.508+/-0.297 microg ml(-1)) within 1h, S(-)-satropane exhibited 3.2-fold greater C(max) and 2.2-fold greater AUC(0-3h) (p<0.05) in the in situ forming gel. The results showed that the in situ forming gel system could improve the ocular bioavailability of S(-)-satropane.
|
Authors | Jun Fu, Xuemei Feng, Haihong Yuan, Liming Yan, Xiaodong Kuang, Zheng Xia, Xiaoling Gao, Cheng Yu, Yang Lu, Hong-Zhuan Chen |
Journal | Journal of pharmaceutical and biomedical analysis
(J Pharm Biomed Anal)
Vol. 48
Issue 3
Pg. 840-3
(Nov 04 2008)
ISSN: 0731-7085 [Print] England |
PMID | 18632240
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Chemical References |
- Gels
- Ophthalmic Solutions
- Tropanes
- satropane
|
Topics |
- Aqueous Humor
(metabolism)
- Area Under Curve
- Biological Availability
- Chromatography, Liquid
(methods)
- Drug Delivery Systems
- Gels
(pharmacokinetics)
- Microdialysis
(methods)
- Molecular Structure
- Ophthalmic Solutions
(administration & dosage, chemistry, pharmacokinetics)
- Stereoisomerism
- Tandem Mass Spectrometry
(methods)
- Tropanes
|